July 7, 2020 / 5:04 PM / a month ago

BRIEF-UCB And Ferring Pharmaceuticals Announce Co-Promotion Of Cimzia®

July 7 (Reuters) - Ucb SA:

* UCB AND FERRING PHARMACEUTICALS ANNOUNCE CO-PROMOTION OF CIMZIA® (CERTOLIZUMAB PEGOL) FOR THE TREATMENT OF ADULTS WITH MODERATE TO SEVERE CROHN’S DISEASE

* FERRING JOINS WITH UCB TO PROMOTE CIMZIA PREFILLED SYRINGE FOR CROHN’S DISEASE IN U.S. Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below